Amarin Corp Plc (AMRN)

[dogn]

New generic entry by Strides
https://www.bqprime.com/business/strides-pharma-jumps-over-8-after-us-fda-approves-drug-to-reduce-heart-issues

https://www.businesstoday.in/amp/markets/company-stock/story/strides-pharma-science-shares-rise-usfda-nod-icosapent-ethyl-capsules-399552-2023-09-25

Shares of Strides Pharma Science Ltd hit their 52 week high after the firm said its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram, from the United States Food & Drug Administration (USFDA).

https://strides.com/
Headquartered in India, Strides Pharma Science Limited is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world's largest manufacturers of soft gelatin capsules.

Their PR “About Icosapent Ethyl” looks like evidence of induced infringement:

https://strides.com/pdf/pressrelease/2023/StridesSEIntimation_23Sep2023.pdf

About Icosapent Ethyl Capsule
Icosapent Ethyl Capsule is a prescription medication used in conjunction with other medicines like statins to reduce the risk of heart attack, stroke and heart issues in those afflicted with cardiovascular disease. The product complements Strides’ range of approved soft gelatin capsules.